E-LIB Suche - Ergebnisse für: Tuccori, Marco

1

Conducting and interpreting disproportionality analyses der..:

Cutroneo, Paola Maria ; Sartori, Daniele ; Tuccori, Marco...
Frontiers in Drug Safety and Regulation. 3 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

2

Peer Review in Pharmacovigilance: Lens on Disproportionalit..:

Raschi, Emanuel ; Salvo, Francesco ; Bate, Andrew...
Drug Safety. 47 (2024) 7 - p. 601-605 , 2024

Link: https://doi.org/10.1007/..

3

Editorial: Traditional and innovative approaches for signal..:

Tuccori, Marco ; Bate, Andrew ; Moretti, Ugo.
Frontiers in Drug Safety and Regulation. 4 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

4

A Cross-National Comparison of Biosimilars Pricing in Argen..:

da Silva Machado, Fernanda Lacerda ; Cañás, Martín ; Urtasun, Martín A....
Therapeutic Innovation & Regulatory Science. 58 (2024) 3 - p. 549-556 , 2024

Link: https://doi.org/10.1007/..

5

The Reporting of a Disproportionality Analysis for Drug Saf..:

Fusaroli, Michele ; Salvo, Francesco ; Begaud, Bernard...
Drug Safety. 47 (2024) 6 - p. 575-584 , 2024

Link: https://doi.org/10.1007/..

6

Comparing clinical trial population representativeness to r..:

Ingrasciotta, Ylenia ; Spini, Andrea ; L'Abbate, Luca...
Pharmacological Research. 200 (2024) - p. 107074 , 2024

Link: https://doi.org/10.1016/..

7

Drug Use Patterns in Myasthenia Gravis: A Real-World Popula..:

Finocchietti, Marco ; Crescioli, Giada ; Paoletti, Olga...
Journal of Clinical Medicine. 13 (2024) 11 - p. 3312 , 2024

Link: https://doi.org/10.3390/..

8

The REporting of A Disproportionality Analysis for DrUg Saf..:

Fusaroli, Michele ; Salvo, Francesco ; Begaud, Bernard...
Drug Safety. 47 (2024) 6 - p. 585-599 , 2024

Link: https://doi.org/10.1007/..

9

Cases of acquired hemophilia A following COVID‐19 vaccines:..:

Roberto, Giuseppe ; Paoletti, Olga ; Ferraro, Sara...
Pharmacoepidemiology and Drug Safety. 32 (2023) 6 - p. 694-699 , 2023

Link: https://doi.org/10.1002/..

10

Drug-Utilization, Healthcare Facilities Accesses and Costs ..:

Convertino, Irma ; Lorenzoni, Valentina ; Gini, Rosa...
Pharmaceuticals. 16 (2023) 3 - p. 465 , 2023

Link: https://doi.org/10.3390/..

11

Potentially inappropriate drug use in myasthenia gravis: a ..:

Crescioli, Giada ; Finocchietti, Marco ; Paoletti, Olga...
Frontiers in Neurology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

12

Signal management and risk minimization strategy: a case st..:

Valdiserra, Giulia ; Mores, Nadia ; Rocchi, Rosalba Elisabetta...
Frontiers in Drug Safety and Regulation. 3 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

13

Comment on: "Deliberate Self-Poisoning: Real-Time Character..:

Cappello, Emiliano ; Valdiserra, Giulia ; Bonaso, Marco...
Drug Safety. 46 (2023) 9 - p. 917-918 , 2023

Link: https://doi.org/10.1007/..

14

Assessing disease activity of rheumatoid arthritis patients..:

Convertino, Irma ; Cazzato, Massimiliano ; Tillati, Silvia...
Frontiers in Pharmacology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

15

Biosimilars approvals by thirteen regulatory authorities: A..:

Machado, Fernanda Lacerda da Silva ; Cañás, Martín ; Doubova, Svetlana V....
Regulatory Toxicology and Pharmacology. 144 (2023) - p. 105485 , 2023

Link: https://doi.org/10.1016/..